29 January 2024 - trading update
The AIM-listed global healthcare group has issued a trading update for the year that ended on 31 December with see-through revenues for the year at a record level of £182.7m (2022: £172.0m). Strong consumer demand, notably in China, drove significant recovery in Kelo-Cote franchise revenue in the second half of the year with revenues of the product rising by 29% (at constant exchange rates) over the year to £63.2m. Underlying profit for the year is expected to be in line with market expectations. The new financial year is expected . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
